Primmune Therapeutics, Inc. is a company that provides Coronavirus disease 2019 (COVID-19), Toll-like receptor, Receptor and more. Primmune Therapeutics, Inc. is headquartered in United States California. Primmune Therapeutics, Inc. was founded in 2017. Primmune Therapeutics, Inc. has a total of 51 patents and 1 literature
What kind of company is Primmune Therapeutics, Inc.?
Primmune Therapeutics, Inc. develops small molecules, orally administered toll-like receptor for cancer immunotherapy and tumors. The firm offers treatment...
What is Primmune Therapeutics, Inc.'s official website?